Morikawa Y - Search Results

1

Lowering of brain endothelial cell barrier function by exposure to 4'-iodo-α-pyrrolidinononanophenone.

Sakai Y, Taguchi M, Morikawa Y, Suenami K, Yanase E, Takayama T, Ikari A, Matsunaga T. Sakai Y, et al. Among authors: morikawa y. Chem Biol Interact. 2022 Sep 1;364:110052. doi: 10.1016/j.cbi.2022.110052. Epub 2022 Jul 21. Chem Biol Interact. 2022. PMID: 35872046

2

Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells.

Matsunaga T, Yamaguchi A, Morikawa Y, Kezuka C, Takazawa H, Endo S, El-Kabbani O, Tajima K, Ikari A, Hara A. Matsunaga T, et al. Among authors: morikawa y. Anticancer Drugs. 2014 Sep;25(8):868-77. doi: 10.1097/CAD.0000000000000112. Anticancer Drugs. 2014. PMID: 24743520

3

Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through up-regulation of aldo-keto reductase 1B10.

Matsunaga T, Morikawa Y, Haga M, Endo S, Soda M, Yamamura K, El-Kabbani O, Tajima K, Ikari A, Hara A. Matsunaga T, et al. Among authors: morikawa y. Toxicol Appl Pharmacol. 2014 Jul 15;278(2):180-9. doi: 10.1016/j.taap.2014.04.024. Epub 2014 May 9. Toxicol Appl Pharmacol. 2014. PMID: 24813866

4

Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome.

Matsunaga T, Yamaji Y, Tomokuni T, Morita H, Morikawa Y, Suzuki A, Yonezawa A, Endo S, Ikari A, Iguchi K, El-Kabbani O, Tajima K, Hara A. Matsunaga T, et al. Among authors: morikawa y. Free Radic Res. 2014 Nov;48(11):1371-85. doi: 10.3109/10715762.2014.957694. Epub 2014 Sep 23. Free Radic Res. 2014. PMID: 25156503

5

Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo-keto reductase 1B10.

Morikawa Y, Kezuka C, Endo S, Ikari A, Soda M, Yamamura K, Toyooka N, El-Kabbani O, Hara A, Matsunaga T. Morikawa Y, et al. Chem Biol Interact. 2015 Mar 25;230:30-9. doi: 10.1016/j.cbi.2015.02.005. Epub 2015 Feb 14. Chem Biol Interact. 2015. PMID: 25686905

6

Up-Regulation of Carbonyl Reductase 1 Renders Development of Doxorubicin Resistance in Human Gastrointestinal Cancers.

Matsunaga T, Kezuka C, Morikawa Y, Suzuki A, Endo S, Iguchi K, Miura T, Nishinaka T, Terada T, El-Kabbani O, Hara A, Ikari A. Matsunaga T, et al. Among authors: morikawa y. Biol Pharm Bull. 2015;38(9):1309-19. doi: 10.1248/bpb.b15-00176. Biol Pharm Bull. 2015. PMID: 26328486 Free article.

7

Sibutramine provokes apoptosis of aortic endothelial cells through altered production of reactive oxygen and nitrogen species.

Morikawa Y, Shibata A, Okumura N, Ikari A, Sasajima Y, Suenami K, Sato K, Takekoshi Y, El-Kabbani O, Matsunaga T. Morikawa Y, et al. Toxicol Appl Pharmacol. 2017 Jan 1;314:1-11. doi: 10.1016/j.taap.2016.11.003. Epub 2016 Nov 9. Toxicol Appl Pharmacol. 2017. PMID: 27838152

8

α-Pyrrolidinononanophenone provokes apoptosis of neuronal cells through alterations in antioxidant properties.

Matsunaga T, Morikawa Y, Kamata K, Shibata A, Miyazono H, Sasajima Y, Suenami K, Sato K, Takekoshi Y, Endo S, El-Kabbani O, Ikari A. Matsunaga T, et al. Among authors: morikawa y. Toxicology. 2017 Jul 1;386:93-102. doi: 10.1016/j.tox.2017.05.017. Epub 2017 May 31. Toxicology. 2017. PMID: 28578026

9

Enhancement of Endothelial Barrier Permeability by Mitragynine.

Matsunaga T, Morikawa Y, Kamase K, Horinouchi M, Sasajima Y, Suenami K, Sato K, Takekoshi Y, Endo S, El-Kabbani O, Ikari A. Matsunaga T, et al. Among authors: morikawa y. Biol Pharm Bull. 2017;40(10):1779-1783. doi: 10.1248/bpb.b17-00117. Biol Pharm Bull. 2017. PMID: 28966251 Free article.

10

Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells.

Endo S, Xia S, Suyama M, Morikawa Y, Oguri H, Hu D, Ao Y, Takahara S, Horino Y, Hayakawa Y, Watanabe Y, Gouda H, Hara A, Kuwata K, Toyooka N, Matsunaga T, Ikari A. Endo S, et al. Among authors: morikawa y. J Med Chem. 2017 Oct 26;60(20):8441-8455. doi: 10.1021/acs.jmedchem.7b00830. Epub 2017 Oct 13. J Med Chem. 2017. PMID: 28976752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,049 results

Search Page